Absorption |
Blood-Brain Barrier | BBB+ | 0.9179 |
Human Intestinal Absorption | HIA+ | 0.9318 |
Caco-2 Permeability | Caco2+ | 0.6414 |
P-glycoprotein Substrate | Non-substrate | 0.5701 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6465 |
Non-inhibitor | 0.8722 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8791 |
Distribution |
Subcellular localization | Mitochondria | 0.9132 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8782 |
CYP450 2D6 Substrate | Non-substrate | 0.8958 |
CYP450 3A4 Substrate | Non-substrate | 0.6139 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5665 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7159 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9161 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.5558 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8929 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5565 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9765 |
Non-inhibitor | 0.8527 |
AMES Toxicity | Non AMES toxic | 0.8552 |
Carcinogens | Non-carcinogens | 0.7105 |
Fish Toxicity | High FHMT | 0.8900 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9347 |
Honey Bee Toxicity | High HBT | 0.5169 |
Biodegradation | Ready biodegradable | 0.6618 |
Acute Oral Toxicity | IV | 0.6070 |
Carcinogenicity (Three-class) | Non-required | 0.5996 |